Your Messages Inbox
Your Article Summary
See Latest ArticlesWatson Pharmaceuticals Appoints Christopher W. Bodine to Board of Directors
Watson Pharmaceuticals, 06/30/09
Watson Pharmaceuticals, Inc. , a leader in generic and specialty branded pharmaceuticals, today announced the appointment of Christopher W. Bodine to its Board of Directors, effective immediately. The addition of Mr. Bodine expands Watson's Board to ten members, of whom nine are independent. Mr. Bodine's career spans 36 years with two of the nation's leading retail and healthcare companies and brings to Watson a significant chain drug industry background.
Today in Execs on the Move...keeping you current
Receive free subspecialty "5-minute updates" via email
Astellas hires new vice president of compliance
Astellas, 09/11/09
Myriad Genetics Elects Louise Phanstiel and Lawrence Best to Its Board of Directors
Myriad, 09/22/09
New Chiefs at Axolotl, CliniComp
HealthDataManagement, 10/30/09
Article Search
Sponsor